Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review

Curr Pain Headache Rep
26 Aug 2020
https://pubmed.ncbi.nlm.nih.gov/32845365/


Purpose of review: The purpose of this review is to evaluate and explain our current understanding of the clinical use of low-dose naltrexone in the treatment of chronic pain.

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

Arthritis Rheum
February 2013
https://pubmed.ncbi.nlm.nih.gov/23359310/​​​​​​​

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

Low-Dose Naltrexone Gaining Recognition as Chronic Pain Treatment

Pain News Network, 23 Nov 2020
https://www.painnewsnetwork.org/stories/2020/11/23/low-dose-naltrexone-gains-recognition-as-chronic-pain-treatment

 

Cory Tichauer, ND - LDN and Lyme Disease I  (2017 Conference) (LDN, low dose naltrexone)

Dr Cory Tichauer shares his presentation on LDN and Lyme Disease at The LDN 2017 Conference.

Dr Tichauer begins by highlighting that Chronic Lyme Disease has many overlapping symptoms from PTLS but can also involve other organ dysfunction due to active infections still causing tissue damage.

 

Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's Thyroid Presentation

 

Jarred Younger, PhD - The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 (2017 Conference) (LDN, low dose naltrexone)

People with rheumatological conditions are much more likely to have fibromyalgia than the general population, Lupus in particular was indicated to be the most likely rheumatological condition where fibromyalgia was also present.